美股A股
StockGist

Novartis AG

NVSNYSE · Healthcare · Drug Manufacturers - General
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide.
$160.50+0.16%
报价 2026-11-13
市值
$303.12B
EV
$307.86B
PE (TTM)
20.2x
预期 PE
–
52 周区间距高点 -4.8%
$124.36$168.62

筛选结果

pipeline · 2026-11-13
Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool

研究结论

还没有研究记录。先生成 L2 基本面报告(约 1–3 分钟),结论会显示在这里。

去生成基本面报告 →

历史股价

加载中…

事件

0 条 · 随区间与图例筛选

该区间内无事件。

同行对比

同行业市值相近 · Drug Manufacturers - General
公司市值今日预期营收增速毛利率PEEV/EBITDAP/FCF池
NVSNovartis AG$303.12B+0.2%–76%20.2x13.5x–
JNJJohnson & Johnson$687.89B+0.8%+8.0%73%21.3x14.9x33.4x
ABBVAbbVie Inc.$521.5B+0.2%+11.1%73.3%86.3x15.1x27.6xGARP
MRKMerck & Co., Inc.$364.27B+0.6%+3.7%73.5%121.5x30.7x23.5x
AZNAstraZeneca PLC$286.06B+0.0%–78.2%27.5x15.4x–
AMGNAmgen Inc.$251.89B-0.3%+8.4%70.5%24.4x12.5x26.3x
GILDGilead Sciences, Inc.$208.48B+0.1%+7.2%81.1%20.0x14.5x14.9x
NVONovo Nordisk A/S$183.52B+2.4%–78.2%10.3x7.2x–Cheap
PFEPfizer Inc.$164.67B+0.2%+1.7%72.8%37.3x17.7x14.7x
同行中位数––+7.6%73.4%26.0x15.0x24.9x

研究全文

L2 基本面 memo

尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。

财务报表

Metric
2026-09-30
Q3 2026
2026-06-30
Q2 2026
2026-03-31
Q1 2026
2025-12-31
Q4 2025
2025-09-29
Q3 2025
2025-06-30
Q2 2025
2025-03-31
Q1 2025
2024-12-31
Q4 2024
Revenue$15.03B$14.42B$13.52B$13.33B$14.36B$14.84B$13.62B$13.56B
Gross Margin76%74.5%74.4%73.4%75.4%77.6%76.3%75.5%
Operating Margin12.3%32.8%31.3%26.4%31.3%32.8%34.2%26%
Net Income$1.2B$3.27B$3.16B$2.41B$3.93B$4.04B$3.61B$2.82B
Diluted EPS0.631.711.651.252.022.061.821.41
Operating Cash Flow$5.5B$5.89B$3.68B$2.25B$6.57B$6.66B$3.65B$4.19B

研究材料

电话会纪要摘要
暂无纪要摘要。